Breast Cancer Drug Repurposed for Infant With Congenital Hyperinsulinism

(MedPage Today) -- A 4-month-old with congenital hyperinsulinism responded well to off-label treatment with a breast cancer drug, researchers reported. A newborn presented with severe congenital hyperinsulinism due to homozygous deletion of the...

https://www.medpagetoday.com/endocrinology/generalendocrinology/108407

Source: MedPage Today Cardiovascular - January 25, 2024 Category: Cardiology Source Type: news